www.fdanews.com/articles/71963-andrx-reports-first-quarter-2005-financial-results
Andrx Reports First Quarter 2005 Financial Results
May 5, 2005
Andrx Corporation announced its financial results for the three months ended March 31, 2005, which are discussed more extensively in Andrx's Form 10-Q being filed with the U.S. Securities and Exchange Commission (SEC). Andrx's Form 10-Q is available on the company's website. Andrx total revenues were $277.7 million for the 2005 first quarter, a 5 percent decrease from $292.2 million total revenues for the 2004 first quarter. The 2005 first quarter included $4.7 million in licensing and royalties revenues compared to $20.1 million in the 2004 first quarter.